Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 40.02% is 70% above its 5-year average of 23.61%, around the middle of its 5-year range (11.73%–61.97%).
As of the fiscal period ended Tuesday, June 30, 2026. 10.13% above its 12-month average of 36.34%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 40.02%.
DEBT TO ASSETS RATIO
40.02%
DEBT TO ASSETS RATIO AVG TTM
36.34%
DEBT TO ASSETS RATIO AVG 3Y
28.56%
DEBT TO ASSETS RATIO AVG 5Y
23.61%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+10.13%
CURRENT VS 3Y AVG
+40.13%
CURRENT VS 5Y AVG
+69.55%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+44371.14%
vs the sector median at left
Sight Sciences, Inc.
Market Cap
$465.75M
Debt to Assets Ratio
40.02%
TTM Avg
36.34%
3Y Avg
28.56%
5Y Avg
23.61%
Market Cap
$469.12M
Debt to Assets Ratio
0.29%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$472.23M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$475.91M
Debt to Assets Ratio
0.03%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$483.54M
Debt to Assets Ratio
0.02%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | $465.75M | 40.02% | 36.34% | 28.56% | 23.61% |
| Kamada Ltd. (KMDA)vs › | $467.90M | 0.03% | N/A | N/A | N/A |
| Alpha Teknova, Inc. (TKNO)vs › | $469.12M | 0.29% | N/A | N/A | N/A |
| Cerus Corporation (CERS)vs › | $471.57M | 0.37% | N/A | N/A | N/A |
| Arvinas, Inc. (ARVN)vs › | $471.65M | 0.01% | N/A | N/A | N/A |
| Bright Minds Biosciences Inc. (DRUG)vs › | $472.23M | 0.00% | N/A | N/A | N/A |
| Contineum Therapeutics, Inc. (CTNM)vs › | $475.91M | 0.03% | N/A | N/A | N/A |
| NRC Health (NRC)vs › | $452.54M | 0.66% | N/A | N/A | N/A |
| Puma Biotechnology, Inc. (PBYI)vs › | $483.54M | 0.02% | N/A | N/A | N/A |
| Capricor Therapeutics, Inc. (CAPR)vs › | $445.71M | 0.25% | N/A | N/A | N/A |
Debt/Assets
40.0%
Debt/Equity
0.79
Current Ratio
4.95
Interest Coverage
-7.2x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 40.02% |
| 2026-03-31 | 38.07% |
| 2025-12-31 | 35.36% |
| 2025-09-30 | 35.00% |
| 2025-06-30 | 33.26% |
| 2025-03-31 | 31.20% |
| 2024-12-31 | 28.26% |
| 2024-09-30 | 24.57% |
| 2024-06-30 | 23.39% |
| 2024-03-31 | 22.50% |
| 2023-12-31 | 21.25% |
| 2023-09-30 | 19.63% |
| 2023-06-30 | 18.77% |
| 2023-03-31 | 17.74% |
| 2022-12-31 | 16.42% |
| 2022-09-30 | 15.25% |
| 2022-06-30 | 14.24% |
| 2022-03-31 | 13.24% |
| 2021-12-31 | 12.21% |
| 2021-09-30 | 11.73% |
| 2021-06-30 | 61.97% |
| 2021-03-31 | 53.68% |
| 2020-12-31 | 44.62% |
